Cargando…
Theranostic nanomedicine for cancer detection and treatment
Cancer is the second leading cause of death in the USA according to the American Cancer Society. In the past 5 years, “theranostic nanomedicine”, for both therapeutics and imaging, has shown to be “the right drug for the right patient at the right moment” to manage deadly cancers. This review articl...
Autores principales: | Fan, Zhen, Fu, Peter P., Yu, Hongtao, Ray, Paresh C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359153/ https://www.ncbi.nlm.nih.gov/pubmed/24673900 http://dx.doi.org/10.1016/j.jfda.2014.01.001 |
Ejemplares similares
-
Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023) -
Stimuli-activatable nanomedicine meets cancer theranostics
por: Li, Haonan, et al.
Publicado: (2023) -
Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
por: Tang, Yufu, et al.
Publicado: (2022) -
Nanomedicines for high‑intensity focused ultrasound cancer treatment and theranostics (Review)
por: Zheng, Qinyun, et al.
Publicado: (2023) -
Recent Progress in Nanomaterial-Based Biosensors and Theranostic Nanomedicine for Bladder Cancer
por: Song, Fan-Xin, et al.
Publicado: (2023)